申请人:SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
公开号:EP0885890A1
公开(公告)日:1998-12-23
A sulfonylureidopyrazole derivative of formula (1) or (2) is disclosed. The derivative has an inhibitory activity on endothelin converting enzyme, and is useful for treating or preventing various cardiac failures, tracheal constrictions, nervous disorders, parasecretion, vascular disorders, various ulcers and the like.
公开了一种化学式(1)或(2)的磺酰脲吡唑衍生物。该衍生物对内皮素转化酶具有抑制活性,可用于治疗或预防各种心脏衰竭、气管收缩、神经紊乱、副分泌、血管紊乱、各种溃疡等疾病。